The recent emergence of artemisinin resistance in the Greater Mekong Subregion poses a major threat to the global effort to control malaria. Tracking the spread and evolution of artemisinin-resistant parasites is critical in aiding efforts to contain the spread of resistance. A total of 417 patient samples from the year 2007, collected during malaria surveillance studies across ten provinces in Thailand, were genotyped for the candidate Plasmodium falciparum molecular marker of artemisinin resistance K13. Parasite genotypes were examined for K13 propeller mutations associated with artemisinin resistance, signatures of positive selection, and for evidence of whether artemisinin-resistant alleles arose independently across Thailand. A total of seven K13 mutant alleles were found (N458Y, R539T, E556D, P574L, R575K, C580Y, S621F). Notably, the R575K and S621F mutations have previously not been reported in Thailand. The most prevalent artemisinin resistance-associated K13 mutation, C580Y, carried two distinct haplotype profiles that were separated based on geography, along the Thai-Cambodia and Thai-Myanmar borders. It appears these two haplotypes may have independent evolutionary origins. In summary, parasites with K13 propeller mutations associated with artemisinin resistance were widely present along the Thai-Cambodia and Thai-Myanmar borders prior to the implementation of the artemisinin resistance containment project in the region.
References
[1]
Noedl H., et al., Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med, 2008. 359(24): p. 2619–20. doi: 10.1056/NEJMc0805011. pmid:19064625
[2]
Vijaykadga S., et al., In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health, 2006. 11(2): p. 211–9. pmid:16451346 doi: 10.1111/j.1365-3156.2005.01557.x
[3]
Wongsrichanalai C., et al., Epidemiology of drug-resistant malaria. Lancet Infect Dis, 2002. 2(4): p. 209–18. pmid:11937421 doi: 10.1016/s1473-3099(02)00239-6
[4]
Wootton J.C., et al., Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature, 2002. 418(6895): p. 320–3. pmid:12124623 doi: 10.1038/nature00813
[5]
Satimai W., et al., Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Malar J, 2012. 11: p. 300. pmid:22929621 doi: 10.1186/1475-2875-11-300
[6]
Alker A.P., et al., Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg, 2007. 76(4): p. 641–7. pmid:17426163
[7]
Phyo A.P., et al., Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet, 2012. 379(9830): p. 1960–6. doi: 10.1016/S0140-6736(12)60484-X. pmid:22484134
[8]
Dondorp A.M., et al., Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med, 2009. 361(5): p. 455–67. doi: 10.1056/NEJMoa0808859. pmid:19641202
[9]
Amaratunga C., et al., Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis, 2012. 12(11): p. 851–8. doi: 10.1016/S1473-3099(12)70181-0. pmid:22940027
[10]
Carrara V.I., et al., Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999–2011: an observational study. PLoS Med, 2013. 10(3): p. e1001398. doi: 10.1371/journal.pmed.1001398. pmid:23472056
[11]
Kyaw M.P., et al., Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One, 2013. 8(3): p. e57689. doi: 10.1371/journal.pone.0057689. pmid:23520478
[12]
Takala-Harrison S., et al., Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A, 2013. 110(1): p. 240–5. doi: 10.1073/pnas.1211205110. pmid:23248304
[13]
Takala-Harrison S., et al., Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia. J Infect Dis, 2014. 211(5):670–9. doi: 10.1093/infdis/jiu491. pmid:25180241
[14]
WHO, Strategic Plan to Strengthen Malaria Control and Elimination in the Greater Mekong Sub region: 2010–2014. 2010: The World Health Organizaiton. Geneva.
[15]
Khamsiriwatchara A., et al., Artemisinin resistance containment project in Thailand. (I): Implementation of electronic-based malaria information system for early case detection and individual case management in provinces along the Thai-Cambodian border. Malar J, 2012. 11: p. 247. doi: 10.1186/1475-2875-11-247. pmid:22839508
[16]
WHO, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. 2008: World Health Organization. Geneva.
[17]
WHO, Global report on antimalarial drug efficacy and drug resistance: 2000–2010. 2010: World Health Organization. Geneva.
[18]
Cheeseman I.H., et al., A major genome region underlying artemisinin resistance in malaria. Science, 2012. 336(6077): p. 79–82. doi: 10.1126/science.1215966. pmid:22491853
[19]
Ariey F., et al., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature, 2014. 505(7481): p. 50–5. doi: 10.1038/nature12876. pmid:24352242
[20]
Ashley E.A., et al., Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med, 2014. 371(5): p. 411–23. doi: 10.1056/NEJMoa1314981. pmid:25075834
[21]
Miotto O., et al., Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet, 2015. 47(3):226–34 doi: 10.1038/ng.3189. pmid:25599401
[22]
Miotto O., et al., Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet, 2013. 45(6): p. 648–55. doi: 10.1038/ng.2624. pmid:23624527
[23]
Nyunt, M.H., et al., Molecular Assessment of Artemisinin Resistance Markers, Polymorphisms in the K13 Propeller, and a Multidrug-Resistance Gene in the Eastern and Western Border Areas of Myanmar. Clin Infect Dis, 2014. pii: ciu1160. [Epub ahead of print]
[24]
Tun, K.M., et al., Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis, 2015. pii: S1473-3099(15)70032-0.
[25]
Straimer J., et al., Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science, 2015. 347(6220): p. 428–31. doi: 10.1126/science.1260867. pmid:25502314
[26]
Pumpaibool T., et al., Genetic diversity and population structure of Plasmodium falciparum in Thailand, a low transmission country. Malar J, 2009. 8: p. 155. doi: 10.1186/1475-2875-8-155. pmid:19602241
[27]
Anderson T.J. and Roper C., The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop, 2005. 94(3): p. 269–80. pmid:15878153 doi: 10.1016/j.actatropica.2005.04.010
[28]
Alam M.T., et al., Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand. Antimicrob Agents Chemother, 2011. 55(1): p. 155–64. doi: 10.1128/AAC.00691-10. pmid:20956597
[29]
WHO, Malaria in the greater Mekong subregion: regional and country profiles. 2008: The World Health Organization. Geneva.
[30]
Alam M.T., et al., Selective sweeps and genetic lineages of Plasmodium falciparum drug-resistant alleles in Ghana. J Infect Dis, 2011. 203(2): p. 220–7. doi: 10.1093/infdis/jiq038. pmid:21288822
[31]
Su X., et al., A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science, 1999. 286(5443): p. 1351–3. pmid:10558988 doi: 10.1126/science.286.5443.1351
[32]
Clark L.V. and Jasieniuk M., POLYSAT: an R package for polyploid microsatellite analysis. Mol Ecol Resour, 2011. 11(3): p. 562–6. doi: 10.1111/j.1755-0998.2011.02985.x. pmid:21481215
[33]
Boc A., Diallo A.B., and Makarenkov V., T-REX: a web server for inferring, validating and visualizing phylogenetic trees and networks. Nucleic Acids Res, 2012. 40(Web Server issue): p. W573–9. doi: 10.1093/nar/gks485. pmid:22675075
[34]
Hay S.I., et al., Developing global maps of the dominant anopheles vectors of human malaria. PLoS Med, 2010. 7(2): p. e1000209. doi: 10.1371/journal.pmed.1000209. pmid:20161718
